title: Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
abstract: Bi-allelic MUTYH gene mutations are associated with a clinical phenotype of multiple colorectal adenomas and an increased risk for colorectal cancer (CRC). It is unclear whether mono-allelic MUTYH gene carriers (heterozygotes) are also at increased risk for even few adenomas or cancer. In order to clarify an association between MUTYH heterozygotes and adenomas, we evaluated the frequency and types of MUTYH mutations and variants in 72 North-African Jews having few (≥3) colorectal adenomas with or without early onset (<50 years) CRC compared to 29 healthy controls. Germ-line DNA was analyzed for a panel of 6 MUTYH mutations and variants, and Sanger sequencing of the entire MUTYH gene was performed for mono-allelic MUTYH mutation carriers. APC gene mutations and Lynch syndrome were excluded in the relevant cases according to accepted clinical criteria. Twenty-two of the 72 adenoma subjects (30.5%) had MUTYH mutations or variants. Nine were homozygotes or compound heterozygotes: all had >10 adenomas and one had CRC. Thirteen others were mono-allelic carriers (heterozygotes) of a single MUTYH mutation: six had more than ten adenomas and seven had less than ten adenomas; of these 13 mono-allelic carriers, six had a neoplasm: three CRCs and three extra-intestinal tumors. Eleven of the thirteen mono-allelic carriers with adenomas had a family history of cancer in first or second degree relatives. A multivariable model showed positive correlation between G396D, Y179C and 1186 ins GG mutations and number of adenomas (OR 8.6, 10.2 and 14.4, respectively). The Q324H variant was negatively associated with the number of adenomatous polyps (OR -5.23). In conclusion, MUTYH mutations are prevalent among Jews of North-African origin with colorectal adenomas with or without early onset CRC. Mono-allelic MUTYH carriers with a family history of cancer had a clinical phenotype that varied from having only few adenomas to multiple (>10) adenomas. These findings support MUTYH testing in patients with even few adenomas and suggest the consideration of increased surveillance in mono-allelic carriers with a family history of cancer.
authors.affiliation: Departmant of Gastroenterology, Tel-Aviv Sourasky Medical Center, 6 Weizmann St., 64239, Tel Aviv, Israel, guyr@tlvmc.gov.il.
authors.forename: Guy
authors.initials: G
authors.lastname: Rosner
authors.forename: Dani
authors.initials: D
authors.lastname: Bercovich
authors.forename: Yael Etzion
authors.initials: YE
authors.lastname: Daniel
authors.forename: Hana
authors.initials: H
authors.lastname: Strul
authors.forename: Naomi
authors.initials: N
authors.lastname: Fliss-Isakov
authors.forename: Meirav
authors.initials: M
authors.lastname: Ben-Yehoiada
authors.forename: Erwin
authors.initials: E
authors.lastname: Santo
authors.forename: Zamir
authors.initials: Z
authors.lastname: Halpern
authors.forename: Revital
authors.initials: R
authors.lastname: Kariv
mesh_terms: D000236:Adenoma / Q000235:genetics*; D018256:Adenomatous Polyps / Q000235:genetics; D000328:Adult; D000352:Africa, Northern / Q000208:ethnology; D000368:Aged; D000483:Alleles; D016022:Case-Control Studies; D015331:Cohort Studies; D015179:Colorectal Neoplasms / Q000235:genetics*; D045647:DNA Glycosylases / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006801:Humans; D007557:Israel / Q000208:ethnology; D007585:Jews / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation
chemical_list: D045647:DNA Glycosylases; C061738:mutY adenine glycosylase
references.citation: Cancer Sci. 2008 Feb;99(2):355-60
references.pmid: 18271935
references.citation: Gastroenterology. 2009 Aug;137(2):489-94, 494.e1; quiz 725-6
references.pmid: 19394335
references.citation: Am J Hum Genet. 2005 Jul;77(1):112-9
references.pmid: 15931596
references.citation: Cancer Res. 2003 Nov 15;63(22):7595-9
references.pmid: 14633673
references.citation: Nat Genet. 2002 Feb;30(2):227-32
references.pmid: 11818965
references.citation: Gastroenterology. 2004 Jul;127(1):9-16
references.pmid: 15236166
references.citation: Br J Cancer. 2010 Dec 7;103(12):1875-84
references.pmid: 21063410
references.citation: Gastroenterology. 2008 Aug;135(2):499-507
references.pmid: 18534194
references.citation: Virchows Arch. 2007 Mar;450(3):311-9
references.pmid: 17252231
references.citation: JAMA. 2012 Aug 1;308(5):485-492
references.pmid: 22851115
references.citation: Gene. 2012 Mar 15;496(1):55-8
references.pmid: 22266422
references.citation: Fam Cancer. 2011 Mar;10(1):1-9
references.pmid: 21061173
references.citation: Clin Genet. 2008 Jun;73(6):545-53
references.pmid: 18422726
references.citation: Gastroenterology. 2009 Apr;136(4):1251-60
references.pmid: 19245865
references.citation: Am J Pathol. 2003 Sep;163(3):827-32
references.pmid: 12937124
references.citation: J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
references.pmid: 14970275
references.citation: BMC Cancer. 2009 Jun 15;9:184
references.pmid: 19527492
references.citation: Int J Cancer. 2006 Aug 15;119(4):807-14
references.pmid: 16557584
references.citation: Clin Gastroenterol Hepatol. 2006 Apr;4(4):499-506
references.pmid: 16616356
references.citation: Isr Med Assoc J. 2010 Sep;12(9):549-53
references.pmid: 21287799
references.citation: Gastroenterology. 2014 May;146(5):1208-11.e1-5
references.pmid: 24444654
references.citation: Curr Genomics. 2008 Sep;9(6):420-35
references.pmid: 19506731
references.citation: Hum Genet. 2006 Mar;119(1-2):206-11
references.pmid: 16408224
references.citation: J Surg Oncol. 2007 May 1;95(6):499-506
references.pmid: 17219385
references.citation: BMC Genomics. 2009 Nov 28;10:561
references.pmid: 19943955
references.citation: Eur J Cancer. 2010 Apr;46(6):1041-8
references.pmid: 20149637
references.citation: Int J Cancer. 2011 Nov 1;129(9):2256-62
references.pmid: 21171015
references.citation: Fam Cancer. 2013 Mar;12(1):43-50
references.pmid: 23007840
references.citation: Fam Cancer. 2007;6(1):43-51
references.pmid: 17039270
references.citation: Fam Cancer. 2009;8(4):525-31
references.pmid: 19685280
references.citation: Gut. 2012 May;61(5):734-8
references.pmid: 21846783
references.citation: Carcinogenesis. 2012 Nov;33(11):2301-9
references.pmid: 22926731
references.citation: BMC Cancer. 2008 Sep 23;8:269
references.pmid: 18811933
references.citation: J Clin Oncol. 2009 Aug 20;27(24):3975-80
references.pmid: 19620482
references.citation: BMC Med Genet. 2009 Jun 16;10:57
references.pmid: 19531215
references.citation: Hum Mutat. 2010 Nov;31(11):1205-15
references.pmid: 20725929
references.citation: J Clin Gastroenterol. 2011 Jul;45(6):488-500
references.pmid: 21325953
references.citation: Int J Cancer. 2004 May 1;109(5):680-4
references.pmid: 14999774
references.citation: Fam Cancer. 2012 Sep;11(3):329-35
references.pmid: 22371070
references.citation: Genet Test. 2005 Summer;9(2):147-51
references.pmid: 15943555